Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target.

CONCLUSIONS: Regenerating the degraded GCX reverses EC barrier dysfunction and may attenuate the progression of vascular disease. PMID: 30988234 [PubMed - as supplied by publisher]
Source: Biorheology - Category: Biochemistry Tags: Biorheology Source Type: research